CIM
BSX icon

Cambria Investment Management’s Boston Scientific BSX Stock Holding History

Cambria Investment Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$604K Buy
14,152
+7,246
+105% +$393K 0.03% 470
2026
Q1 		$433K Buy
6,906
+1,895
+38% +$152K 0.02% 447
2025
Q4 		$478K Buy
+5,011
New +$491K 0.03% 423

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Cambria Investment Management's BSX Position: Q2 2026 in Review

Cambria Investment Management increased its Boston Scientific (BSX) stake by 105% in Q2 2026, buying an estimated $393K and bringing the position to 14,152 shares worth $604K. The position accounts for 0.03% of the portfolio, ranked #470.

Cambria Investment Management first reported a position in BSX in Q4 2025 and has held it in 3 quarters since. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Cambria Investment Management held 14,152 shares of Boston Scientific worth $604K as of Q2 2026.
  • Cambria Investment Management bought 7,246 Boston Scientific shares in Q2 2026, an estimated $393K.
  • Boston Scientific made up 0.03% of Cambria Investment Management's portfolio in Q2 2026, its #470 holding.
  • Cambria Investment Management first reported a position in Boston Scientific in Q4 2025 and has held it in 3 quarters since.
  • 1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Cambria Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.